SARS CoV 2 News and Research

RSS

High altitude may act as a protective factor against COVID-19

The analysis by researchers from Spain and Peru reveals that high altitude confers significant protection from coronavirus disease (COVID-19) infection and death – independent of the distance from the pandemic epicenter, population density, or poverty levels. The study is currently available on the medRxiv preprint server.

5 Aug 2020

New medical imaging resource center at UChicago will help tackle COVID-19 pandemic

A new center hosted at the University of Chicago -- co-led by the largest medical imaging professional organizations in the country -- will help tackle the ongoing COVID-19 pandemic by curating a massive database of medical images to help better understand and treat the disease.

5 Aug 2020

SARS-CoV-2 may not be targeting taste bud cells

An intriguing early symptom among some COVID-19 patients is the loss of the sense of smell and/or taste, which has led to the suspicion that the virus that causes the illness, SARS-CoV-2, could be targeting taste buds.

5 Aug 2020

Study reveals changes in transmissibility of SARS-CoV-2 due to D614G spike mutation

A recent research endeavor from the UK, currently available on the medRxiv preprint server, indicates that spike 614G variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increases in frequency relative to 614D variant in a selective advantage manner – but without higher coronavirus disease (COVID-19) mortality rates.

5 Aug 2020

A SARS-CoV-2 assay using plant proteins

Researchers in South Africa have developed a serological assay that readily detects antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using recombinant viral proteins produced in plants.

5 Aug 2020

NIH-Moderna investigational vaccine protects mice from infection with SARS-CoV-2

The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according to research published today in Nature.

5 Aug 2020

Evidence for antibody longevity in COVID-19 patients

A study led by researchers at the University of Toronto, Canada, has found evidence that immunoglobulin G (IgG) antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are sustained for at least three months.

5 Aug 2020

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

New COVID-19 test evaluates herd immunity and vaccine efficacy with high accuracy.

5 Aug 2020

Existing drug used to treat alcoholism is potentially effective against COVID-19

A team of chemists from HSE University and the Zelinsky Institute of Organic Chemistry used molecular modelling to find out that two medications that have been known for a long time can be used to fight SARS-CoV-2.

5 Aug 2020

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

5 Aug 2020

Study shows higher COVID-19 rates among minority and socioeconomically disadvantaged children

Minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection, a new study led by Children's National Hospital researchers shows.

5 Aug 2020

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

A laboratory test that has now been developed by a study group from MedUni Vienna is able to determine whether COVID-19 patients develop protective antibodies after having the disease.

5 Aug 2020

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

In a new study published on the preprint server bioRxiv researchers characterized the crystal structure of the antibody-SARS-CoV-2 RBD complex in an attempt to find the epitope and the mechanism that enables cross-neutralization.

5 Aug 2020

Large proportion of UK healthcare workers may have already had Covid-19 infection

A large proportion of UK healthcare workers may already have been infected with Covid-19, according to new research led by the University of East Anglia in collaboration with University College London.

5 Aug 2020

Embryos are susceptible to COVID-19 if mothers get sick, indicates study

Genes that are thought to play a role in how the SARS-CoV-2 virus infects our cells have been found to be active in embryos as early as during the second week of pregnancy, say scientists at the University of Cambridge and the California Institute of Technology (Caltech).

5 Aug 2020

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Now, Regeneron Pharmaceuticals says its COVID-19 antibody-drug cocktail under development prevented and treated the disease in monkeys and hamsters, showing promise that it may work in humans.

5 Aug 2020

Study: "Memory" T cells that recognize common cold coronaviruses also recognize SARS-CoV-2

Your immune system's "memory" T cells keep track of the viruses they have seen before. This immune cell memory gives the cells a headstart in recognizing and fighting off repeat invaders.

5 Aug 2020

De novo protein decoys that block SARS-CoV-2

Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.

5 Aug 2020

Dire COVID-19 warning from World Health Organization

The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a “silver bullet” to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

5 Aug 2020

Can Vitamin D help combat the coronavirus?

In a new report published in The Lancet, a team of researchers discussed the possibility that vitamin D could offer protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The meta-analyses of randomized controlled trials performed from 2007 to 2020.

4 Aug 2020

SARS CoV 2 News and Research

High altitude may act as a protective factor against COVID-19

New medical imaging resource center at UChicago will help tackle COVID-19 pandemic

SARS-CoV-2 may not be targeting taste bud cells

Study reveals changes in transmissibility of SARS-CoV-2 due to D614G spike mutation

A SARS-CoV-2 assay using plant proteins

NIH-Moderna investigational vaccine protects mice from infection with SARS-CoV-2

Evidence for antibody longevity in COVID-19 patients

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

Existing drug used to treat alcoholism is potentially effective against COVID-19

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

Study shows higher COVID-19 rates among minority and socioeconomically disadvantaged children

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

Large proportion of UK healthcare workers may have already had Covid-19 infection

Embryos are susceptible to COVID-19 if mothers get sick, indicates study

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Study: "Memory" T cells that recognize common cold coronaviruses also recognize SARS-CoV-2

De novo protein decoys that block SARS-CoV-2

Dire COVID-19 warning from World Health Organization

Can Vitamin D help combat the coronavirus?

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News